Cara Therapeutics Inc (NAS:CARA)
$ 0.378 -0.0719 (-15.98%) Market Cap: 20.73 Mil Enterprise Value: -13.94 Mil PE Ratio: 0 PB Ratio: 37.80 GF Score: 35/100

Cara Therapeutics Inc Corporate Update Call Transcript

Jan 22, 2024 / 01:30PM GMT
Release Date Price: $0.5587 (-1.12%)
Operator

Good day. Thank you for standing by, and welcome to Cara Therapeutics' Corporate Update Conference Call. (Operator Instructions) Please note that today's conference is being recorded. I would now like to introduce Matt Murphy, gas Manager of Investor Relations. Please go ahead.

Matt Murphy Cara Therapeutics
Inc. - IR

Thank you, operator, and good morning. This morning, Cara issued a news release announcing the company's corporate strategy, focus and update. Copies of this news release and the associated SEC filing can be found in the Investors section of our website at www.caratherapeutics.com.

Before we begin, let me remind you that during this conference call, we will be making certain forward-looking statements about Cara and our programs based on management's current plans and expectations. These statements are being made under the Private Securities Litigation Reform Act of 1995 and are subject to risks and uncertainties.

Actual results may differ materially due to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot